Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
12 pending office actions • 11 art units • 12 examiners • 0 of 12 (0%) have an AI response strategy ready • 22 patents granted in the last 365 days
Kansas State University Research Foundation has 12 pending office actions within the Biotechnology & Pharmaceuticals technology area. These cases are assigned to 12 distinct examiners, ensuring that no single examiner is managing more than 1 pending action. This distribution across 12 distinct examiners is paired with 11 distinct art units, showing a wide technical footprint for the university's research. This distribution requires the applicant to manage 12 separate prosecution timelines simultaneously.
The busiest examiner, BAZARGANI, ARYA AHMADI, is currently handling 1 pending office action. Because the 12 pending office actions are spread across 11 distinct art units, the prosecution requires addressing the specific requirements of nearly a dozen different specialized groups. This structure suggests that the 12 distinct examiners are largely operating independently within their respective units. The involvement of 12 distinct examiners means that the university must be prepared for 12 unique approaches to prior art rejections.
Because the 12 pending office actions are spread across 11 distinct art units, practitioners must monitor for potential conflicts in prosecution across different technical divisions. This broad distribution underscores the complexity of the university's current engagement with the USPTO. The 12 pending office actions represent a significant workload that requires careful coordination to ensure consistent claim language across the Biotechnology & Pharmaceuticals portfolio. The lack of concentration under a single examiner means that each case requires a unique strategy.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (17%) |
| §112 only | 1 (8%) |
| Double-patenting + other | 3 (25%) |
| Multi-statute (no §101) | 6 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BAZARGANI, ARYA AHMADI | 1 | 62.5% | +31.3% |
| WANG, RUIXUE | 1 | 55.9% | +19.0% |
| KUMAR, VINOD | 1 | 82.8% | +20.3% |
| DUFFY, PATRICIA ANN | 1 | 52.9% | +33.9% |
| SABILA, MERCY HELLEN | 1 | 57.5% | +45.3% |
| WATTS, JENNA A | 1 | 48.6% | +54.0% |
| SALVOZA, M FRANCO G | 1 | 68.2% | +30.6% |
| HAWKINS, AMANDA SALATA | 1 | 15.4% | +40.9% |
| BERNATZ, KEVIN M | 1 | 87.8% | +12.3% |
| KWIATKOWSKA, LIDIA | 1 | 68.9% | +20.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18924027 | DEVELOPMENT OF MOSAIC VACCINES AGAINST FOOT AND MOUTH DISEASE VIRUS SEROTYPE ASIA | WANG, RUIXUE | — |
| 18913587 | ANTIVIRAL HAIRPIN CONSTRUCTS AND METHODS OF USE THEREOF | KUMAR, VINOD | — |
| 18841203 | ANAPLASMA VACCINES AND METHODS OF USE THEREOF | DUFFY, PATRICIA ANN | — |
| 18720832 | ECO-FRIENDLY ADDITIVES FOR HAY AND SILAGE INOCULANTS MINIMIZING GREENHOUSE GAS EMISSIONS | WATTS, JENNA A | — |
| 18417359 | CHEMICAL MITIGANTS IN ANIMAL FEED AND FEED INGREDIENTS | HAWKINS, AMANDA SALATA | — |
| 18476651 | ELECTROCHEMICAL CATALYSTS FOR FUEL CELLS AND METHODS OF MAKING AND USING THE SAME | BERNATZ, KEVIN M | — |
| 17559397 | SYSTEM AND METHOD FOR AN AGRICULTURAL APPLICATOR | AHMED, ISTIAQUE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18131739 | SYSTEM AND METHOD FOR AN AGRICULTURAL APPLICATOR | KWIATKOWSKA, LIDIA | 26d |
| 18860868 | CORRALLING AMPHIPATHIC PEPTIDE COLLOIDS | BAZARGANI, ARYA AHMADI | — |
| 18924027 | DEVELOPMENT OF MOSAIC VACCINES AGAINST FOOT AND MOUTH DISEASE VIRUS SEROTYPE ASIA | WANG, RUIXUE | — |
| 18913587 | ANTIVIRAL HAIRPIN CONSTRUCTS AND METHODS OF USE THEREOF | KUMAR, VINOD | — |
| 18841203 | ANAPLASMA VACCINES AND METHODS OF USE THEREOF | DUFFY, PATRICIA ANN | — |
| 18722010 | CYCLIC PEPTIDE FOR CANCER IMMUNOTHERAPY | SABILA, MERCY HELLEN | — |
| 18720832 | ECO-FRIENDLY ADDITIVES FOR HAY AND SILAGE INOCULANTS MINIMIZING GREENHOUSE GAS EMISSIONS | WATTS, JENNA A | — |
| 18547842 | BOVINE VIRAL DIARRHEA VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF | SALVOZA, M FRANCO G | — |
| Art Unit | Apps |
|---|---|
| 1672 | 2 |
| 1613 | 1 |
| 1663 | 1 |
| 1645 | 1 |
| 1654 | 1 |
| 1791 | 1 |
| 1793 | 1 |
| 1735 | 1 |
| 3666 | 1 |
| 1614 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18860868 | CORRALLING AMPHIPATHIC PEPTIDE COLLOIDS | BAZARGANI, ARYA AHMADI | 1613 | §102§103§112DP | Non-Final OA | — | Pending | Oct 28, 2024 |
| 18924027 | DEVELOPMENT OF MOSAIC VACCINES AGAINST FOOT AND MOUTH DISEASE VIRUS SEROTYPE ASIA | WANG, RUIXUE | 1672 | §102§103§112 | Non-Final OA | — | Pending | Oct 23, 2024 |
| 18913587 | ANTIVIRAL HAIRPIN CONSTRUCTS AND METHODS OF USE THEREOF | KUMAR, VINOD | 1663 | §103§112 | Non-Final OA | — | Pending | Oct 11, 2024 |
| 18841203 | ANAPLASMA VACCINES AND METHODS OF USE THEREOF | DUFFY, PATRICIA ANN | 1645 | §102§112 | Non-Final OA | — | Pending | Aug 23, 2024 |
| 18722010 | CYCLIC PEPTIDE FOR CANCER IMMUNOTHERAPY | SABILA, MERCY HELLEN | 1654 | §112 | Non-Final OA | — | Pending | Jun 20, 2024 |
| 18720832 | ECO-FRIENDLY ADDITIVES FOR HAY AND SILAGE INOCULANTS MINIMIZING GREENHOUSE GAS EMISSIONS | WATTS, JENNA A | 1791 | §102§103 | Non-Final OA | — | Pending | Jun 17, 2024 |
| 18547842 | BOVINE VIRAL DIARRHEA VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF | SALVOZA, M FRANCO G | 1672 | §103§112DP | Non-Final OA | — | Pending | Mar 18, 2024 |
| 18417359 | CHEMICAL MITIGANTS IN ANIMAL FEED AND FEED INGREDIENTS | HAWKINS, AMANDA SALATA | 1793 | §103§112DP | Final Rejection | — | Pending | Jan 19, 2024 |
| 18476651 | ELECTROCHEMICAL CATALYSTS FOR FUEL CELLS AND METHODS OF MAKING AND USING THE SAME | BERNATZ, KEVIN M | 1735 | §102§103 | Non-Final OA | — | Pending | Sep 28, 2023 |
| 18131739 | SYSTEM AND METHOD FOR AN AGRICULTURAL APPLICATOR | KWIATKOWSKA, LIDIA | 3666 | §103 | Final Rejection | 26d | Pending | Apr 06, 2023 |
| 17997276 | ENCAPSULATED COMPOSITIONS AND USE OF OCTENYLSUCCINIC ANHYDRIDE STARCH AS EMULSIFYING AGENT | PRAGANI, RAJAN | 1614 | §103 | Final Rejection | 31d overdue | Pending | Oct 27, 2022 |
| 17559397 | SYSTEM AND METHOD FOR AN AGRICULTURAL APPLICATOR | AHMED, ISTIAQUE | 2116 | §102§103 | Non-Final OA | — | Pending | Dec 22, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialKansas State University Research Foundation has 12 pending office actions as of October 2026, spread across 11 art units and 12 examiners.
Arya Ahmadi Bazargani has the most, with 1 of Kansas State University Research Foundation's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
